Combining regulation with suppression and aiming for tolerance.
Cobbold
Stephen P
SP
Therapeutic Immunology Group, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. stephen.cobbold@path.ox.ac.uk
D019264:Adoptive Transfer; D000818:Animals; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D004195:Disease Models, Animal; D051858:Forkhead Transcription Factors / Q000032:analysis; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D053645:Interleukin-2 Receptor alpha Subunit / Q000032:analysis; D007519:Isoantigens / Q000276:immunology; D051379:Mice; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology / Q000637:transplantation; D013997:Time Factors; D023001:Transplantation Tolerance / Q000187:drug effects*
D019013:CD40 Antigens; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; C508018:Il2ra protein, mouse; D007166:Immunosuppressive Agents; D053645:Interleukin-2 Receptor alpha Subunit; D007519:Isoantigens; D023201:CD40 Ligand